Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
about
Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemiaModern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroupsChronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelEnhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurementHodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.Chronic lymphocytic leukemia in young individuals revisited.Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
P2860
Q33437042-A38AA159-10B2-4E9E-B773-934D861504ADQ33913537-1F11C1BE-64DF-449A-9498-96F14873EFEFQ34272532-ADFED2B9-4ABD-4991-AB4C-A7DCEB6A2858Q34711271-5BD075BA-2908-4CED-888B-344BF80F2102Q35626311-9B4C1E02-AE19-42B5-A88A-1243C7457820Q36294042-6461910E-CFA4-4295-9C9F-3540B6A70DA8Q38594789-164DAEFC-1DB8-4255-95FA-731C88C4F5BCQ38680890-DF251542-0337-4725-BA12-344D4874AE3DQ38792651-92D13011-1805-4A50-8BAE-2BD2736627B6Q39277021-FE1CE5CD-1CFD-4B28-B949-2F5FF7372D4EQ40784167-04708C77-3634-419C-9292-B7E40DFA8A24Q42551352-CDE7AB17-3E35-4469-ABCA-62F9169E50AAQ50569242-9D702131-E060-4388-B4AE-4FC9F753543BQ58776981-F03EE982-17A0-41D7-8E82-493A5DEA784E
P2860
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@ast
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@en
Chronic lymphocytic leukemia in young
@nl
type
label
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@ast
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@en
Chronic lymphocytic leukemia in young
@nl
prefLabel
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@ast
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@en
Chronic lymphocytic leukemia in young
@nl
P2093
P2860
P1433
P1476
Chronic lymphocytic leukemia i ...... rognostic factors and outcomes
@en
P2093
Deborah A Bowen
Diane F Jelinek
Kari G Rabe
Michael Conte
Neil E Kay
Sameer A Parikh
Susan L Slager
Susan M Schwager
Tait D Shanafelt
Timothy G Call
P2860
P304
P356
10.3324/HAEMATOL.2013.086066
P577
2013-08-02T00:00:00Z